Status:
COMPLETED
Extension for Menopause Sample Collection
Lead Sponsor:
SPD Development Company Limited
Conditions:
Menopause
Eligibility:
FEMALE
18+ years
Brief Summary
This study will provide urine samples from women going through the menopause transition in order to maintain the SPD sample bank. Symptom information and cycle length will also be recorded to observe...
Detailed Description
This is an extension to a previous sample collection (Protocol-1326) where additional samples will be collected from the women who continue to go through the menopausal transition (i.e. are not post-m...
Eligibility Criteria
Inclusion
- Pre- and peri-menopausal volunteers(assigned by STRAW+10 criteria) who completed PROTOCOL-1326
Exclusion
- Post-menopausal volunteers (12 months since last menstrual period)
- Use of hormone replacement therapy (HRT)
- Use of hormone contraception
- Hysterectomy and/or oophorectomy
- Pregnant or breast feeding
- Other medical reason for amenorrhea (absence of menstruation)
Key Trial Info
Start Date :
January 22 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 7 2025
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT06171373
Start Date
January 22 2024
End Date
May 7 2025
Last Update
May 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
SPD Development Company Ltd
Bedford, Bedfordshire, United Kingdom, MK44 3UP